FHC
AXSM icon

First Horizon Corporation’s Axsome Therapeutics AXSM Stock Holding History

First Horizon Corporation’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Sell
487
-63
-11% -$13.7K ﹤0.01% 502
2026
Q1 		$93K Sell
550
-51
-8% -$8.81K ﹤0.01% 508
2025
Q4 		$110K Buy
601
+325
+118% +$45.4K ﹤0.01% 495
2025
Q3 		$33.5K Buy
+276
New +$31.1K ﹤0.01% 709
2021
Q2 		$0 Buy
+13
New +$780 ﹤0.01% 1070

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return

First Horizon Corporation's AXSM Position: Q2 2026 in Review

First Horizon Corporation reduced its Axsome Therapeutics (AXSM) stake by 11% in Q2 2026, selling an estimated $13.7K and leaving 487 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

First Horizon Corporation first reported a position in AXSM in Q2 2021 and has held it in 5 quarters since. 44 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • First Horizon Corporation held 487 shares of Axsome Therapeutics worth $119K as of Q2 2026.
  • First Horizon Corporation sold 63 Axsome Therapeutics shares in Q2 2026, an estimated $13.7K.
  • Axsome Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #502 holding.
  • First Horizon Corporation first reported a position in Axsome Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 44 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.